ALFOLD MEDICAL AESTHETICS LTD
Opportunity 61/100 (worth a look), bankability 55/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Confirmation statement overdue. Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: low (52/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Mixed signal. Worth opening the full target workup before deciding to pursue.
Recent activity
Corporate timeline (3 events)Click to expand
- 2025-06-13🏢Company incorporatedAs ALFOLD MEDICAL AESTHETICS LTD
- 2025-06-13➕FRYER, Dana Christina appointeddirector
- 2025-06-13📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.1 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
1 high ·Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.
Evidence: Next due: 2026-06-26
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dana Christina Fryer Individual · British · DOB 01/1987 · age 39 | 75–100% | — | 75-100% shares | 13/06/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · RH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ADVANCED RESPONSE LTD→ 11965182 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AK FOOTCARE LTD→ 16440667 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AKATSUKI MEDICAL LTD→ 15122326 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AKMD MEDICAL SERVICES LIMITED→ 09518514 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| AKOPYAR LIMITED→ 08854251 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ALANIC ENGINEERING LIMITED→ 01280887 · est 1976 · no financials extracted | — | — | — | — | 49y | — | — |
| ALCHEMY CARE HOLDINGS LIMITED→ 12525247 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| ALEX CLIFF LIMITED→ 09977315 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ALEXIAN BROTHERS OF THE PROVINCE OF THE SACRED HEART (THE)→ 00773307 · est 1963 · no financials extracted | — | — | — | — | 62y | — | — |
| ALI 786 SERVICES LTD→ 13121508 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ALICE CARE RECRUITMENT LIMITED→ 14558395 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ALIYA DRAKE THERAPY LTD→ 15802004 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
9 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.